160 related articles for article (PubMed ID: 20221580)
1. [PET/CT imaging of atherosclerotic blood vessel alterations].
Rominger A; Rist C; Nikolaou K; Reiser MF; Bartenstein P; Hacker M; Saam T
Radiologe; 2010 Apr; 50(4):355-65. PubMed ID: 20221580
[TBL] [Abstract][Full Text] [Related]
2. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
3. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
[TBL] [Abstract][Full Text] [Related]
4. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.
Ben-Haim S; Kupzov E; Tamir A; Frenkel A; Israel O
J Nucl Cardiol; 2006 Nov; 13(6):791-800. PubMed ID: 17174810
[TBL] [Abstract][Full Text] [Related]
7. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Wassélius J; Larsson S; Jacobsson H
Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
[TBL] [Abstract][Full Text] [Related]
8. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
[TBL] [Abstract][Full Text] [Related]
10. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques.
Kwee RM; Truijman MT; Mess WH; Teule GJ; ter Berg JW; Franke CL; Korten AG; Meems BJ; Prins MH; van Engelshoven JM; Wildberger JE; van Oostenbrugge RJ; Kooi ME
AJNR Am J Neuroradiol; 2011 May; 32(5):950-4. PubMed ID: 21330389
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT Imaging of Carotid Atherosclerosis.
Ali A; Tawakol A
Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries.
Okane K; Ibaraki M; Toyoshima H; Sugawara S; Takahashi K; Miura S; Shimosegawa E; Satomi J; Kitamura K; Satoh T
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):589-94. PubMed ID: 16491424
[TBL] [Abstract][Full Text] [Related]
14. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
[TBL] [Abstract][Full Text] [Related]
15. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
16. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
[TBL] [Abstract][Full Text] [Related]
17. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
[TBL] [Abstract][Full Text] [Related]
19. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
20. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]